Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

NCT06596252 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: Budesonide

Sponsor

Dr. Falk Pharma GmbH